Skip to main content
. Author manuscript; available in PMC: 2013 Nov 13.
Published in final edited form as: Eur J Cancer. 2012 Aug 23;48(18):10.1016/j.ejca.2012.06.027. doi: 10.1016/j.ejca.2012.06.027

Fig. 3.

Fig. 3

(A and B). A pancreas cancer patient treated at 240 mg/m2 indicated that a liver lesion had a complete pS6 inhibition at 22.5-h after the 8th dose of SF1126 and (C and D). A skin punch of the same patient showed pS6 continued to be elevated pre- and post-SF1126 treatment (261 min).